Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2024
Archives
Advancing vaccine development for chlamydia
Genital Chlamydia trachomatis infection is a significant public health burden; Professor of Pediatrics and Microbiology and Immunology, Toni Darville, discusses the potential efficacy of CPAF-adjuvanted vaccines in mitigating the spread and impact of the infection.
Vaccine hesitancy and the challenge of successful scientific communication
Drawing on personal experiences and public discourse, Dr. Klaus Eyer, an Associate Professor at Aarhus University, explores the challenges of communicating about vaccine science to address vaccine hesitancy.
Catalysing vaccines and biologics manufacturing in Africa
Professor Faith Osier, Director of the Chanjo Hub at Imperial College London, shares her vision for vaccines and biologics manufacturing in Africa to secure lives and livelihoods and drive economic growth.
Persistent anti-vaxxers and pandemic-induced new anti-vaxxers
Read this analysis of persistent anti-vaxxers and pandemic-induced new anti-vaxxers by Fujio Toriumi, Professor at the University of Tokyo in Japan.
Innovative packaging design enhances vaccine accessibility for developing countries
Unither Pharmaceuticals is dedicated to innovating and expanding capacity to provide equitable vaccine accessibility in developing countries and enhance preparedness for future pandemics. Here, they explain how the Euroject® device can support their goals.
The challenge of generating lasting mucosal anti-viral sterilising immunity
Achieving sterilising immunity is often challenging and sometimes even impossible. This article gives a glimpse into the concepts behind and highlights some recent advances and challenges.
Learning from the COVID-19 Pandemic: Next-generation universal vaccines and immunotherapeutic research
With the COVID-19 pandemic behind us, we need to focus on universal vaccines and/or immunotherapeutic strategies and technologies to tackle ongoing endemic infections with SARS-CoV2, influenza, and RSV and prepare for any future pandemics, says Dr Babita Agrawal.
Building global health with lego vaccines
Prof Tuck Seng Wong and Dr Kang Lan Tee from the University of Sheffield, explain building global health with LEGO vaccines.
Vaccine non-responders and severe adverse events
Eyer Klaus, an Associate Professor at Aarhus University’s Department of Biomedicine, explores the causes, impact, and potential resolutions of vaccine non-responsiveness and severe side effects.
Navigating koala conservation challenges with advanced tech and game-changing vaccine research
Discover the intricate tale of koala survival, from habitat struggles to the rise of Chlamydia vaccines, in this exclusive interview with Professor Peter Timms from The University of Sunshine Coast, Australia.
Microbe development for the biomanufacturing age
Joe Price, Dr Kang Lan Tee & Prof Tuck Seng Wong, explore adopting a holistic approach to microbe development for the age of biomanufacturing.
Effective vaccines for non-communicable diseases – A pipe dream?
Markus Mandler, Founder and CEO of Tridem Bioscience, explains how the company’s cutting-edge vaccine platform is revolutionising treatment approaches and vaccines for non-communicable diseases (NCDs).
